ArticleClinical pharmacokinetics2025

Population Modeling of Factor IX Activity Following Administration of Fidanacogene Elaparvovec Gene Therapy in Participants with Hemophilia B.

Jessica Wojciechowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.